Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature

International Journal of Infectious Diseases

Volumn 14, Issue 4, 2010, Pages

  Jossi, M ^a   Ambrosioni, J ^a   Macedo Vinas, M ^a   Garbino, J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Fusarium solani fungemia; Invasive fusariosis; Leukemia; Posaconazole

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; POSACONAZOLE; VALACICLOVIR; VANCOMYCIN; VORICONAZOLE;

ADULT; AGRANULOCYTOSIS; ARTICLE; BACTEREMIA; BLOOD CULTURE; CASE REPORT; COMORBIDITY; DIARRHEA; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; FUNGEMIA; FUSARIOSIS; FUSARIUM SOLANI; HUMAN; HUMAN TISSUE; LYMPHATIC LEUKEMIA; MYCOSIS; SKIN BIOPSY;

ADULT; ANTIFUNGAL AGENTS; DERMATOMYCOSES; FATAL OUTCOME; FEMALE; FUSARIUM; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 77949492510     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.05.004     Document Type: Article

References (27)

1. Garbino J., Uckay I., Rhoner P., Lew D., and Van Delden C. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 18 (2005) 613-618
2. Nucci M., and Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20 (2007) 695-704
3. Nelson P.E., Dignani M.C., and Anaissie E.J. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 7 (1994) 479-504
4. Dignani M.C., and Anaissie E. Human fusariosis. Clin Microbiol Infect 10 (2004) 67-75
5. Bushelman S.J., Callen J.P., Roth D.N., and Cohen L.M. Disseminated Fusarium solani infection. J Am Acad Dermatol 32 (1995) 346-351
6. Boutati E.I., Anaissie E.J., and Fusarium. a significant emerging pathogen in patients with hematologic malignancy: ten years experience at a cancer centre and implications for management. Blood 90 (1997) 999-1008
7. Guarro J., and Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 14 (1995) 741-754
8. Velasco E., Martins C., and Nucci M. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis 14 (1995) 697-699
9. Marr K.A., Seidel K., Slavin M.A., Bowden R.A., Schoch H.G., and Boekh M. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow up of a randomized, placebo-controlled trial. Blood 96 (2000) 2055-2061
10. Winston D.J., Pakrasi A., and Busuttil R.W. Prophylactic fluconazole in liver transplant recipients: a randomized, doubleblind, placebo-controlled trial. Ann Intern Med 131 (1999) 729-737
11. Mowbray D.N., Paller A.S., Nelson P.E., and Kaplan R.L. Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol 27 (1988) 698-701
12. Singh N., Gayowski T., Singh J., and Yu V.L. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 20 (1995) 617-620
13. Maertens J., Lagrou K., Deweerdt H., Surmont I., Verhoef G.E., Verhaegen J., et al. Disseminated infection by Scedosporium prolificans: emerging fatality among hematology patients. Ann Hematol 79 (2000) 340-344
14. Hennequin C., Lavarde V., Poirot J.L., Rabodonirina M., Datry A., Aractingi S., et al. Invasive Fusarium infections: a retrospective survey of 31 cases. J Med Vet Mycol 35 (1997) 107-114
15. Gamis A.S., Gudnason T., Giebink G.S., and Ramsay N.K. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 13 (1991) 1077-1088
16. Krcmery Jr. V., Kunova E., Jesenska Z., Trupl J., Spanik S., Mardiak J., et al. Invasive mold infections in cancer patients: 5 years experience with Aspergillus, Mucor, Fusarium and Acremonium infections. Support Care Cancer 4 (1996) 39-45
17. Liu K., Howell D.N., Perfect J.R., and Schnell W.A. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 109 (1998) 45-54
18. Krcmery Jr. V., Jesenska Z., Spanik S., Gyarfas J., Nogova J., Botek R., et al. Fungaemia due to Fusarium spp in cancer patients. J Hosp Infect 36 (1997) 223-228
19. McGinnis M.R., Pasarell L., Sutton D.A., Fothergill A.W., Cooper Jr. C.R., and Rinaldi M.G. In vitro activity of voriconazole against selected fungi. Med Mycol 36 (1998) 239-242
20. Pujol I., Guarro J., Gene J., and Sala J. In vitro antifungal susceptibility of clinical and environmental Fusarium spp strains. J Antimicrob Chemother 39 (1997) 163-167
21. Speeleveld E., Gordts B., Van Landuyt H.W., De Vroey C., and Raes-Wuytack C. Susceptibility of clinical isolates of Fusarium to antifungal drugs. Mycoses 39 (1996) 37-40
22. Cornely O.A. Aspergillus to zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection 36 (2008) 296-313
23. Katyar S.K., and Edlind T.D. Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in yeast. Antimicrob Agents Chemother 53 (2009) 1772-1778
24. Sutton D.A. Laboratory evaluation of new antifungal agents against rare and refractory mycoses. Curr Opin Infect Dis 15 (2002) 575-582
25. Consigny S., Dhedin N., Datry A., Choquet S., Leblond V., and Chosidow O. Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 37 (2003) 311-313
26. Perfect J.R., Marr K.A., Walsh T.J., Greenberg R.N., DuPont B., de la Torre-Cisneros J., et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 36 (2003) 1122-1131
27. Guarro J., Nucci M., Akiti T., Gené J., Barreiro M.D., and Gonçalves R.T. Fungemia due to Fusarium sacchari in an immunosuppressed patient. J Clin Microbiol 38 (2000) 419-421